Phase 3 Trial


Inovio Pharmaceuticals Phase 3 HPV Immunotherapy Vaccine Receives “Best Therapeutic Vaccine” at World Vaccine Congress

Inovio Pharmaceuticals announced  VGX-3100, its Phase 3 immunotherapy to treat cervical dysplasia, was selected for the "Best Therapeutic Vaccine" award at the World Vaccine Congress held in Washington, D.C. Each year, the Vaccine Industry Excellence (ViE) award...

Huons Completes Phase 3 Trials for Hutox

Huons Global completed phase 3 clinical trials for Hutox, its botulinum (BTX) strain. Based in South Korea, the company offers oral solid form products in the areas of circulatory system, metabolic, anti-pyretic analgesic anti-inflammatory, musculoskeletal system,...

Pin It on Pinterest